256 related articles for article (PubMed ID: 26065870)
1. Contralateral Prophylactic Mastectomy: Factors Predictive of Occult Malignancy or High-Risk Lesion and the Impact of MRI and Genetic Testing.
Erdahl LM; Boughey JC; Hoskin TL; Degnim AC; Hieken TJ
Ann Surg Oncol; 2016 Jan; 23(1):72-7. PubMed ID: 26065870
[TBL] [Abstract][Full Text] [Related]
2. Occult Histopathology and Its Predictors in Contralateral and Bilateral Prophylactic Mastectomies.
Mattos D; Gfrerer L; Ling IT; Reish RG; Hughes KS; Halpern EF; Cetrulo C; Colwell AS; Winograd JM; Yaremchuk MJ; Austen WG; Liao EC
Ann Surg Oncol; 2016 Mar; 23(3):767-75. PubMed ID: 26577123
[TBL] [Abstract][Full Text] [Related]
3. Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients.
Chung A; Huynh K; Lawrence C; Sim MS; Giuliano A
Ann Surg Oncol; 2012 Aug; 19(8):2600-6. PubMed ID: 22396004
[TBL] [Abstract][Full Text] [Related]
4. Impact of breast reconstruction on the decision to undergo contralateral prophylactic mastectomy.
Ashfaq A; McGhan LJ; Pockaj BA; Gray RJ; Bagaria SP; McLaughlin SA; Casey WJ; Rebecca AM; Kreymerman P; Wasif N
Ann Surg Oncol; 2014 Sep; 21(9):2934-40. PubMed ID: 24756811
[TBL] [Abstract][Full Text] [Related]
5. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.
Arrington AK; Jarosek SL; Virnig BA; Habermann EB; Tuttle TM
Ann Surg Oncol; 2009 Oct; 16(10):2697-704. PubMed ID: 19653045
[TBL] [Abstract][Full Text] [Related]
6. Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy?
McLaughlin SA; Stempel M; Morris EA; Liberman L; King TA
Cancer; 2008 Mar; 112(6):1214-21. PubMed ID: 18257089
[TBL] [Abstract][Full Text] [Related]
7. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.
Pesce C; Liederbach E; Wang C; Lapin B; Winchester DJ; Yao K
Ann Surg Oncol; 2014 Oct; 21(10):3231-9. PubMed ID: 25081341
[TBL] [Abstract][Full Text] [Related]
8. Contralateral prophylactic mastectomy in an Asian population: a single institution review.
Sim Y; Tan VK; Ho GH; Wong CY; Madhukumar P; Tan BK; Yong WS; Ng YY; Ong KW
Breast; 2014 Feb; 23(1):56-62. PubMed ID: 24275318
[TBL] [Abstract][Full Text] [Related]
9. Predictors that influence contralateral prophylactic mastectomy election among women with ductal carcinoma in situ who were evaluated for BRCA genetic testing.
Elsayegh N; Kuerer HM; Lin H; Gutierrez Barrera AM; Jackson M; Muse KI; Litton JK; Albarracin C; Afrough A; Hortobagyi GN; Arun BK
Ann Surg Oncol; 2014 Oct; 21(11):3466-72. PubMed ID: 24796968
[TBL] [Abstract][Full Text] [Related]
10. Rate of contralateral prophylactic mastectomy is influenced by preoperative MRI recommendations.
Xia C; Schroeder MC; Weigel RJ; Sugg SL; Thomas A
Ann Surg Oncol; 2014 Dec; 21(13):4133-8. PubMed ID: 24934585
[TBL] [Abstract][Full Text] [Related]
11. Incremental risk associated with contralateral prophylactic mastectomy and the effect on adjuvant therapy.
Eck DL; Perdikis G; Rawal B; Bagaria S; McLaughlin SA
Ann Surg Oncol; 2014 Oct; 21(10):3297-303. PubMed ID: 25047470
[TBL] [Abstract][Full Text] [Related]
12. Is routine sentinel lymph node biopsy indicated in women undergoing contralateral prophylactic mastectomy? Magee-Womens Hospital experience.
Soran A; Falk J; Bonaventura M; Keenan D; Ahrendt G; Johnson R
Ann Surg Oncol; 2007 Feb; 14(2):646-51. PubMed ID: 17122987
[TBL] [Abstract][Full Text] [Related]
13. Contralateral prophylactic mastectomy: clinical and pathological features from a prospective database.
Barry PN; Johnson RR; Harkenrider MM; Freeman AB; Kruse B; Wilson MR; Pan J; Dragun AE
Am J Med Sci; 2012 Dec; 344(6):452-6. PubMed ID: 22395715
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node biopsy in contralateral prophylactic mastectomy: are we overtreating? Experience at a tertiary care hospital.
Kuwajerwala NK; Dekhne NS; Pentiak PA; Fend D; Callahan RE; Amine M; Lucia V; Swartz J
Clin Breast Cancer; 2013 Aug; 13(4):287-91. PubMed ID: 23706482
[TBL] [Abstract][Full Text] [Related]
15. Perceptions of contralateral breast cancer: an overestimation of risk.
Abbott A; Rueth N; Pappas-Varco S; Kuntz K; Kerr E; Tuttle T
Ann Surg Oncol; 2011 Oct; 18(11):3129-36. PubMed ID: 21947590
[TBL] [Abstract][Full Text] [Related]
16. The value of breast MRI in high-risk patients with newly diagnosed breast cancer to exclude invasive disease in the contralateral prophylactic mastectomy: Is there a role to choose wisely patients for sentinel node biopsy?
Freitas V; Crystal P; Kulkarni SR; Ghai S; Bukhanov K; Escallon J; Scaranelo AM
Cancer Med; 2016 Jun; 5(6):1031-6. PubMed ID: 26992816
[TBL] [Abstract][Full Text] [Related]
17. Breast magnetic resonance imaging for preoperative locoregional staging.
Hollingsworth AB; Stough RG; O'Dell CA; Brekke CE
Am J Surg; 2008 Sep; 196(3):389-97. PubMed ID: 18436185
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of expert criteria for preoperative magnetic resonance imaging of newly diagnosed breast cancer.
Behrendt CE; Tumyan L; Gonser L; Shaw SL; Vora L; Paz IB; Ellenhorn JD; Yim JH
Breast; 2014 Aug; 23(4):341-5. PubMed ID: 24530008
[TBL] [Abstract][Full Text] [Related]
19. Predictors for contralateral prophylactic mastectomy in breast cancer patients.
Fu Y; Zhuang Z; Dewing M; Apple S; Chang H
Int J Clin Exp Pathol; 2015; 8(4):3748-64. PubMed ID: 26097557
[TBL] [Abstract][Full Text] [Related]
20. Changing surgical trends in young patients with early stage breast cancer, 2003 to 2010: a report from the National Cancer Data Base.
Pesce CE; Liederbach E; Czechura T; Winchester DJ; Yao K
J Am Coll Surg; 2014 Jul; 219(1):19-28. PubMed ID: 24862886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
